Celldex Therapeutics reported $54.2M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Agenus USD 642K 399K Sep/2025
Amgen USD 1.6B 187M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Celldex Therapeutics USD 54.2M 8.94M Jun/2025
Glaxosmithkline GBP 3.47B 461.37M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pfizer USD 4.59B 1.7B Mar/2026
Rigel Pharmaceuticals USD 8.03M 5.22M Sep/2024
Roche Holding CHF 8.48B 4.61B Dec/2025